CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
chest computed tomography scanprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00601146
NCT00601146N/ACompleted

Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease

Dana-Farber Cancer Institute·interventional·Posted Jan 25, 2008·Updated Jan 21, 2020

In Brief

A clinical study evaluating chest computed tomography scan for Lung Cancer. Completed, enrolled 39 participants across 2 sites.

Detailed Summary

This research study is being done because patients with a history of chest radiation treatment for Hodgkin's disease have been shown to be at increased risk for developing lung cancer a number of years out from treatment. The risk appears to be further increased among patients with a smoking history. Currently, the practice is to recommend annual low-dose chest CT scans in survivors of Hodgkin's disease who have received prior chest radiation treatment and who have at least a moderate smoking history. In this study, the CT scans will be read and interpreted by the study radiologist, and the results recorded in a consistent manner.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesUnited States

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 25, 2008
Enrollment StartNov 1, 2006
Primary CompletionDec 1, 2010
Study CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 18.4 years ago

Interventions

chest computed tomography scanprocedure

Once a year for three years